Acute myeloid leukaemia (AML)is a type of fast-growing leukaemia that starts in the bone marrow and prevents normal blood cell production. It results in maladies such as fatigue, infections, and easy bruising. Early detection and modern treatments, including chemotherapy and targeted therapies, can improve outcomes.

Key Takeaways

AML is a rapid blood and bone marrow cancer.

It crowds out healthy blood cells, causing symptoms.

It is more common in older adults.

Diagnosis involves blood tests and bone marrow examination.

Treatment may include chemotherapy, targeted therapy, or a stem cell transplant.

AML is a fast-growing blood cancer that starts in the bone marrow and affects the body’s ability to make healthy blood cells. Symptoms often appear quickly, which is why doctors begin treatment soon after diagnosis. With modern therapies and timely care, many patients today have better treatment options and improved outcomes. The moment someone hears the word leukaemia, everything feels uncertain. Conversations become quieter. Questions grow louder. Families begin searching for answers while trying to stay calm. Acute myeloid leukaemia, often called AML, moves quickly, which makes the diagnosis feel even more overwhelming. But understanding what the disease is, how it develops, and how doctors treat it can reduce fear. Clear knowledge helps patients and families face the journey with more confidence, better decisions, and a stronger sense of direction.

What Is Acute Myeloid Leukaemia

Acute myeloid leukaemia is a fast-growing cancer of the blood and bone marrow. The bone marrow normally produces healthy red cells, white cells, and platelets. In AML, the marrow starts producing abnormal white blood cells called myeloblasts. These abnormal cells do not mature properly. They build up quickly and crowd out healthy blood cells. This leads to symptoms such as fatigue, infections, and easy bruising. Because AML progresses rapidly, doctors usually begin treatment soon after diagnosis. Today, advanced [anticancer medicine](https://www.mrmed.in/condition/anti-cancer) helps doctors target these abnormal cells more precisely than in the past.

Who Is Most at Risk

AML can affect both adults and children, but it appears more often in older adults. Some factors increase the risk. Common risk factors include: *

Age above 60 years

Previous chemotherapy or radiation

Certain genetic disorders

Long-term exposure to chemicals like benzene

Smoking history

Many people develop AML without any clear risk factor, so early symptom awareness remains important.

Where AML Starts in the Body

AML begins inside the bone marrow, the soft tissue found in the centre of bones. This is where blood cells normally form. As abnormal cells multiply, they spill into the bloodstream. In some cases, they may collect in organs (liver, spleen, or lymph nodes). This spread can cause swelling, discomfort, or other symptoms.

When Symptoms Usually Appear

Symptoms often develop quickly because AML progresses fast. Many people notice changes within a few weeks. Common symptoms include: *

Extreme tiredness or weakness

Frequent infections

Fever without a clear cause

Easy bruising or bleeding

Shortness of breath

Pale skin

These symptoms happen because the body lacks healthy blood cells.

How Doctors Diagnose and Treat AML

The first step in diagnosing leukaemia is a blood test looking for abnormal cells. If the test shows abnormal cells, a bone marrow biopsy is performed to confirm the diagnosis. In leukaemia, genetic testing can identify specific mutations, guiding treatment options. Chemotherapy is the primary treatment for leukaemia, as it kills leukaemia cells. Doctors may also want to add a targeted anti-cancer medicine to improve the results of the chemotherapy. One targeted therapy is [Midostar 25mg capsule](https://www.mrmed.in/medicines/midostar-25mg-capsule), which contains [Midostaurin](https://www.mrmed.in/molecule/midostaurin) and can be used in patients who carry certain genetic mutations. Midostar are given under the supervision of specialists, along with standard treatment. Some patients with leukaemia may ultimately require a stem cell transplant as their form of treatment. A stem cell transplant replaces the diseased bone marrow with healthy stem cells, allowing normal blood production.

Key Differences Between Healthy Bone Marrow and AML

Feature	Healthy Bone Marrow	AML-Affected Bone Marrow
Cell production	Balanced and controlled	Overproduction of abnormal cells
Red blood cells	Normal levels	Reduced, causing fatigue
White blood cells	Fight infection effectively	Abnormal cells that cannot protect the body
Platelets	Support normal clotting	Low levels, causing bleeding or bruising

What’s Worth Remembering?

Acute myeloid leukaemia (AML) is a type of blood cancer that develops quickly and can be treated with up-to-date therapies. Thanks to advances in early identification, targeted therapies, and supportive care, the long-term outcomes of patients diagnosed with AML have improved. By better understanding AML, families have been able to replace their fear with knowledge; therefore, they will be able to ask the correct questions and to take an active part in their own treatment decisions and recovery.

Reticulocytosis